Skip to content
‹ Back to IndustriesHealthcare

Private Equity and Venture Capital Are Transforming Healthcare – But at What Cost?

Host Kevin Stevenson and guest Dr. Roy Smythe examine the growing influence of private equity and venture capital in healthcare, which totaled $47 billion in deals from 2019 to 2023. They discuss how profit-driven investment can conflict with patient care missions while also accelerating innovation in AI and proteomics. The episode highlights systemic underinvestment in primary care as a core driver of healthcare inefficiency.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from I Don't Care on MarketScale.

By Kevin Stevenson · · Dr. Roy SmythePrivate Capital in HealthcarePrivate Equity and Venture Capital InvestmentsPrivate Equity in Healthcare
Share

Key takeaways

01

Private equity and venture capital poured $47 billion into healthcare deals between 2019 and 2023, reshaping hospitals and physician practices.

02

AI and proteomics represent high-potential innovation areas, but profit motives can undermine alignment with patient care outcomes.

03

Chronic underinvestment in primary care is a root cause of the U.S. healthcare system's inefficiencies and inequities.

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Private equity and venture capital have been reshaping the healthcare landscape, with $47 billion in related deals recorded from 2019 to 2023. These investments promise innovation and growth in AI, diagnostics, and healthcare delivery. However, they also raise critical questions about aligning profit-driven goals with the mission to improve patient care and system efficiency. At a time when the U.S. healthcare system faces mounting inefficiencies and inequities, this influx of private capital demands a closer look.

What does private equity mean for the future of healthcare? Will it spark meaningful innovation or deepen existing challenges in accessibility, affordability, and patient outcomes?

On this episode of I Don't Care, host, Dr. Kevin Stevenson, sits down with Dr. Roy Smythe, a distinguished thoracic surgeon turned venture capital advisor. Together, they explore the impact of private equity and venture capital investments on healthcare systems and physician practices. The discussion uncovers both the opportunities and potential pitfalls of private capital in healthcare.

Episode Highlights:

  • Private Equity and Healthcare Systems: Dr. Smythe critiques the influx of private capital in hospitals and physician groups, suggesting that profit motives can conflict with the mission of patient care and systemic improvement.
  • Advancements in AI and Proteomics: The discussion delves into how AI can improve efficiency and allow for better clinician-patient interactions, while proteomics offers groundbreaking diagnostic potential by analyzing proteins rather than genes.
  • Systemic Inefficiencies and Underinvestment: The U.S. healthcare system remains hampered by a lack of investment in primary care, leading to increased reliance on costly, advanced care. This has perpetuated inequities and inefficiencies despite significant technological progress.

Dr. Roy Smythe is a transformational leader with a diverse background in healthcare innovation, translational bioscience, and medical technology. His career includes executive roles at SomaLogic, Philips, and MD Anderson, where he has driven advancements in diagnostics, AI, and life sciences. With a strong foundation in clinical care and strategic leadership, Dr. Smythe has been at the forefront of bridging medicine and technology to improve healthcare delivery.

I Don't Care

Part of this channel

I Don't Care

Candid healthcare leadership conversations with Kevin Stevenson

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

Kevin Stevenson
Kevin StevensonTop Hospital Administrator & Healthcare COO, I Don't Care
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

Medicus report projects 24% more surgery center cases and 2027 anesthesiology, GI shortages

Medicus report projects 24% more surgery center cases and 2027 anesthesiology, GI shortages

Ambulatory surgery center volumes are projected to rise 24% over the next decade, with anesthesiology and gastroenterology shortages projected for 2027. That puts potential staffing constraints early in the growth period, so operators planning coverage may find the nearer 2027 date sets the pace.

  • 01A 24% ten-year forecast and a 9% forecast for 2023 to 2028 measure different windows; check the time frame and start year before putting either in a budget.
  • 02With about nine in ten ASCs at least partly physician-owned, a staffing gap could hit physician owners directly as clinicians and investors.

Oct 30, 2026

TheraPanacea's CEO says software, not hardware, will scale radiotherapy

TheraPanacea's CEO says software, not hardware, will scale radiotherapy

TheraPanacea CEO Nikos Paragios said at ASTRO 2026 in Boston that vendor-agnostic AI software like ART-Plan can raise radiotherapy throughput on existing machines. A February 2025 Lancet Oncology study puts the global linac shortfall at 30%, with 36 of 181 countries owning no linac, limiting how far software alone can go.

  • 01A February 2025 Lancet Oncology study found a global median Linac Shortage Index of 130, a 30% capacity shortfall, and 36 of 181 countries with no linac at all.
  • 02Bundled adaptive systems already exist: Varian’s Ethos won FDA clearance in February 2020 and RaySearch demoed automated replanning at ASTRO, but buyers still need to validate acceptability and sign-off workflows.

Oct 29, 2026

Berg Insight expects 160 million home medical monitors in care programs by 2030

Berg Insight expects 160 million home medical monitors in care programs by 2030

Prescribed connected home medical monitors are forecast to grow from 92.7 million in 2025 to 159.7 million by 2030. Fastest growth is in diabetes, remote ECG and medication compliance, spread across many suppliers. Berg and IoT Business News argue value depends on integrating data into workflows.

  • 01159.7 million prescribed home medical monitors expected by 2030, growing at 11.5 percent annually from 92.7 million in 2025.
  • 02Sleep therapy is the largest connected segment, followed by diabetes with 19.5 million connections at end of 2025, with fastest future growth in diabetes, remote ECG and medication compliance monitoring.
  • 03Clinical value increasingly depends on integrating data across devices into workflows: vendors combine hardware, software, analytics and interoperability with existing healthcare systems.

Oct 26, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Experts

Kevin Stevenson
Kevin Stevenson

Host, I Don't Care

I Don't Care

Kevin Stevenson is the host of I Don't Care, a MarketScale podcast focused on the challenges healthcare executives and administrators face. He engages with industry leaders to explore the logistics, technology, and innovation enabling better patient care. Stevenson holds a doctorate and has a background in healthcare administration and strategy.

DR
Dr. Roy Smythe

Venture Capital Advisor and Thoracic Surgeon

SomaLogic / Philips / MD Anderson (former executive roles)

Dr. Roy Smythe is a transformational leader with a background spanning thoracic surgery, healthcare innovation, and medical technology. He has held executive roles at SomaLogic, Philips, and MD Anderson Cancer Center, driving advancements in diagnostics, AI, and life sciences. He now advises venture capital firms on healthcare and translational bioscience investments.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512